Beyond-use dates and expiration dates on GLP-1 products

How to read different medication dates and resolve storage questions with the dispensing pharmacy.

In this guide

Similar-looking dates may answer different questions

A medication package can carry a manufacturer’s expiration date, a pharmacy’s beyond-use date and instructions that change after first use. Do not assume the latest printed date overrides the others. Identify what each date refers to and which instruction applies to the product’s current condition. If the label is unclear, contact the dispensing pharmacy rather than choosing the interpretation that leaves the most time.

An expiration date depends on storage conditions

FDA explains that expiration dating is supported by stability information under the labeled storage conditions. It is not a guarantee that a product remains suitable after any temperature exposure or handling. A package arriving with an unexpected condition therefore raises a separate question from whether the printed date has passed. Give the pharmacy the relevant delivery details and follow its product-specific assessment.[1]

A beyond-use date applies to the compounded preparation

USP describes a beyond-use date as the point after which a compounded medicine must not be used. It should not be treated as interchangeable with the manufacturer’s expiration date on an ingredient. The preparation, container and applicable conditions matter. This article does not calculate a replacement date because that requires information about the actual product and the basis used by the dispensing pharmacy.[2]

First use can add another instruction

Ask whether opening or first use changes the permitted storage period and how that event should be recorded. Do not borrow an in-use period from a different pen, vial or formulation. If there are multiple instructions, have the pharmacist explain how they work together. Keep the answer with the medication rather than relying on a memory of what applied to a previous prescription. Related reading: vial and pen questions.

Do not use appearance as a stability test

A product looking unchanged does not establish its strength, quality or suitability after a date or storage concern. FDA’s explanation of stability testing is a reminder that these judgments rely on evidence, not simply visual inspection. Conversely, an unexpected appearance should be raised with the pharmacy even before the printed date. The right next step is product-specific guidance, not an improvised home test.[1]

A bulk purchase can create a timing problem

Before paying for several months, ask whether the supplied medication can be used within its labeled dates under the prescribed plan. A commercial commitment period is not a statement about product stability. Request clarification if the billing period, shipment quantity and use instructions do not seem to align. Do not extend use simply to avoid wasting a prepaid supply.

Document delivery and storage uncertainty

If a shipment is delayed or arrives in an unexpected condition, retain the packaging and relevant times while contacting the pharmacy. Ask who determines whether replacement is needed and how that decision will be communicated. A customer-service assurance should not substitute for a product-specific pharmacy answer. Keep the clinical question separate from the refund or replacement policy, since both may need resolution.

Avoid internet date extensions

FDA describes limited expiration extensions supported by testing, including selected stockpile programs. Those situations do not authorize a patient to extend a date on a home-stored product. Different storage histories and products cannot be treated as equivalent. Use the pharmacy and official product instructions to resolve the actual case, and preserve the distinction between an approved medicine and a compounded preparation.[1] Related reading: branded and compounded products.

Continue your research

Sources & scope

Sources checked October 13, 2026. This guide explains published information and consumer research questions; it is not a clinical evaluation.

  1. FDA: expiration-date questions and answers
  2. USP: compounded medicines and beyond-use dates

Prices and terms can change. Confirm your specific offer directly with the provider.

One more option